Abstract
Objective: To provide a didactic review of the pathophysiology and treatment of Chronic Obstructive Pulmonary Disease (COPD). Bibliographic review: COPD is a lung condition characterized by chronic and progressive airway obstruction, often associated with prolonged exposure to irritants. Its pathophysiology involves continuous inflammation of the airways, which results in damage to the lung parenchyma and, consequently, causes respiratory difficulties. Its prevalence is around 10% to 15% of the global population, making it the third leading cause of death worldwide. The diagnosis of the disease is made through patient history, physical examination, chest X-ray, and pulmonary function tests. Treatment includes medications such as bronchodilators, which are used to open the airways, along with oxygen therapy in cases of significant O2 drop. Final considerations: In summary, COPD is a condition that requires immediate diagnosis and prompt treatment to prevent complications that may worsen the patient’s condition.
References
AARON SD, et al. Early diagnosis and treatment of chronic obstructive pulmonary disease: the costs and benefits of case finding. Am J Respir Crit Care Med, 2024; 209(8): 928-937.
AGUSTÍ A, et al. COPD 2020: Changes and challenges. Am J Physiol Lung Cell Mol Physiol, 2020; 319(5): 879-883.
AGUSTÍ A, et al. Gold copd document 2023: a brief update for practicing cardiologists. Clin Res Cardiol, 2024; 113(2): 195-204.
CHRISTENSON SA, et al. Chronic obstructive pulmonary disease. Lancet, 2022; 399(10342): 2227-2242.
CORHAY JL, et al. Chronic obstructive pulmonary disease. A chronic inflammatory disease. Université de Liège. Revue Médicale de Liège, Liège, Be, 2022; (5-6): 295-301.
DONOHUE JF, et al. Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 2023; 18: 1611-1622.
HALPIN DM. Mortality of patients with COPD. Expert Rev Respir Med, 2024; 18(6): 381-395.
KAHNERT K, et al. The diagnosis and treatment of COPD and its comorbidities. Deutsches Ärzteblatt International, 2023; 120(25): 434–444.
KATZENBERG G, et al. Management of chronic obstructive pulmonary disease. British Journal of Hospital Medicine, 2021; 82(7): 1-10.
KEDIA YS, et al. Chronic obstructive pulmonary disease and oxygen therapy: a double-edged sword. J Assoc Physicians India, 2024; 72(6): 87-90.
LAI S e GUO Z. Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option. Stem Cell Res Ther, 2024; 15(1): 312.
LEAP J, et al. Pathophysiology of COPD. Critical Care Nursing Quarterly, 2021; 44(1): 2-8.
LONG B e REZAIE SR. Evaluation and Management of Asthma and Chronic Obstructive Pulmonary Disease Exacerbation in the Emergency Department. Emerg Med Clin North Am, 2022; 40(3): 539-563.
MACLEOD M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology, 2021; 26(6): 532-551.
MERLO JR e BACKUS D. Chronic Obstructive Pulmonary Disease, Part 1: Disease State Review. Sr Care Pharm, 2023; 38(6): 214-222.
OLSCHEWSKI H, et al. Chronic obstructive pulmonary disease: the right treatment for the right patient. Der Internist, 2021; 62(6): 679–685.
SCARAMUZZO G, et al. Mechanical ventilation and COPD: from pathophysiology to ventilatory management. Minerva Med, 2024; 113(3): 460-470.
SCHWALK AJ, et al. Developing interventions for chronic obstructive pulmonary disease. Semin Respir Crit Care Med, 2024; 45(5): 582-592.
SINGH D. Pharmacological treatment of stable chronic obstructive pulmonary disease. Respirology, 2021; 26(7): 643-651.
WANG FY, et al. Annual research progress in chronic obstructive pulmonary disease. Jie He He Hu Xi ZaZhi, 2025; 48(1): 60-65.
